Cosmos Health unit Cana signs 5-year Provident deal to make 385,000 CERTORUN units

Cosmos Health Inc

Cosmos Health Inc

COSM

0.00
  • Cosmos Health unit Cana signed a new five-year contract manufacturing agreement with Provident Pharmaceuticals for 385,000 units of CERTORUN.
  • Annual production volume set at 77,000 units over the contract term.
  • Order covers CERTORUN sertraline hydrochloride capsules in 50 mg and 100 mg strengths.
  • Manufacturing will run on Cana’s newly installed ACG capsule-filling production line.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606091530PRIMZONEFULLFEED9734299) on June 09, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.